Direct health care costs of hospital admissions due to adverse events in the Netherlands

Abstract Background Although the benefits of physiotherapy is well supported in the literature, the impact of having direct access to physiotherapy is not well established. Update of the current available evidence is warranted. The aim of this systematic review was to update the current evidence regarding the impact of direct access physiotherapy compared to usual care for patients with musculoskeletal disorders. Methods Systematic searches were conducted in 5 bibliographic databases up until May 2018. Two independent raters reviewed studies and used the Quality Assessment Tool for Quantitative Studies to conduct the methodological quality assessment and a data extraction regarding patient outcomes, adverse events, health care utilization and processes, patient satisfaction and health care costs. Results Sixteen studies of weak to moderate quality were included. Five studies found no significant differences in pain reduction between usual family physician led care and direct access physiotherapy. However, three studies reported better clinical outcomes in patients with direct access in terms of function and quality of life. Five studies did not observe any adverse events with direct access physiotherapy. Three studies showed shorter waiting time and four studies reported fewer number of physiotherapy visits with direct access. Three studies showed that patients with direct access were less likely to have medication and imaging tests prescribed compared to usual care. Five studies reported higher levels of satisfaction for direct access. In terms of health care costs, four studies demonstrated that costs were lower with direct access and one study reported similar costs between both types of care. Conclusions Emerging evidence, although of weak to moderate quality, suggest that direct access physiotherapy provides equal or better outcomes than family physician led care models for musculoskeletal disorders patients. More methodologically strong studies are needed. Key messages This review supports the efficacy, safety and cost-effectiveness of direct access PT, while increasing access to care with a more efficient use of resources. There is a need for more methodologically strong studies to evaluate the efficiency of direct access models of care of physiotherapy for patients with MSKD.

Download Full-text

Health care costs of depression in primary care patients in The Netherlands

Family Practice ◽

10.1093/fampra/cmq033 ◽

2010 ◽

Vol 27 (5) ◽

pp. 542-548 ◽

Cited By ~ 10

Author(s):

J. E. Bosmans ◽

M. C. de Bruijne ◽

M. R. de Boer ◽

H. van Hout ◽

P. van Steenwijk ◽

...

Keyword(s):

Primary Care ◽

Health Care ◽

The Netherlands ◽

Health Care Costs ◽

Primary Care Patients ◽

Care Costs

Download Full-text

PDB26 Effect of Diabetes Disease Management Programs Based on Bundled Payment on Curative Health Care Costs in the Netherlands

Value in Health ◽

10.1016/j.jval.2012.08.1669 ◽

2012 ◽

Vol 15 (7) ◽

pp. A498

Author(s):

S.M. Mohnen ◽

C.C. Molema ◽

C.A. Baan ◽

J.T. de Jong-van Til ◽

J.N. Struijs

Keyword(s):

Health Care ◽

Disease Management ◽

The Netherlands ◽

Health Care Costs ◽

Disease Management Programs ◽

Bundled Payment ◽

Care Costs

Download Full-text

Cost of Illness and Disease Burden in The Netherlands Due to Infections with Shiga Toxin–Producing Escherichia coli O157

Journal of Food Protection ◽

10.4315/0362-028x.jfp-10-252 ◽

2011 ◽

Vol 74 (4) ◽

pp. 545-552 ◽

Cited By ~ 20

Author(s):

LUQMAN TARIQ ◽

JUANITA HAAGSMA ◽

ARIE HAVELAAR

Keyword(s):

Escherichia Coli ◽

Health Care ◽

The Netherlands ◽

Health Care Costs ◽

Cost Of Illness ◽

Shiga Toxin ◽

Disease Burden ◽

Escherichia Coli O157 ◽

Discounted Costs ◽

Care Costs

Infections with Shiga toxin–producing Escherichia coli O157 (STEC O157) are associated with hemorrhagic colitis, hemolytic uremic syndrome (HUS), and end-stage renal disease (ESRD). In the present study, we extend previous estimates of the burden of disease associated with STEC O157 with estimates of the associated cost of illness in The Netherlands. A second-order stochastic simulation model was used to calculate disease burden as disability-adjusted life years (DALYs) and cost of illness (including direct health care costs and indirect non–health care costs). Future burden and costs are presented undiscounted and discounted at annual percentages of 1.5 and 4%, respectively. Annually, approximately 2.100 persons per year experience symptoms of gastroenteritis, leading to 22 cases of HUS and 3 cases of ESRD. The disease burden at the population level was estimated at 133 DALYs (87 DALYs discounted) per year. Total annual undiscounted and discounted costs of illness due to STEC O157 infection for the Dutch society were estimated at €9.1 million and €4.5 million, respectively. Average lifetime undiscounted and discounted costs per case were both €126 for diarrheal illness, both €25,713 for HUS, and €2.76 million and €1.22 million, respectively, for ESRD. The undiscounted and discounted costs per case of diarrheal disease including sequelae were €4,132 and €2,131 , respectively. Compared with other foodborne pathogens, STEC O157 infections result in relatively low burden and low annual costs at the societal level, but the burden and costs per case are high.

Download Full-text

Health Care Costs Associated to Type of Feeding in the First Year of Life

International Journal of Environmental Research and Public Health ◽

10.3390/ijerph17134719 ◽

2020 ◽

Vol 17 (13) ◽

pp. 4719

Author(s):

Carolina Lechosa-Muñiz ◽

María Paz-Zulueta ◽

María Sáez de Adana Herrero ◽

Elsa Cornejo del Rio ◽

Sonia Mateo Sota ◽

...

Keyword(s):

Primary Care ◽

Health Care ◽

Infectious Diseases ◽

Emergency Room ◽

Health Care Costs ◽

Medical Records ◽

Hospital Admissions ◽

First Year ◽

First Year Of Life ◽

Care Costs

Background: Breastfeeding is associated with lower risk of infectious diseases, leading to fewer hospital admissions and pediatrician consultations. It is cost saving for the health care system, however, it is not usually estimated from actual cohorts but via simulation studies. Methods: A cohort of 970 children was followed-up for twelve months. Data on mother characteristics, pregnancy, delivery and neonate characteristics were obtained from medical records. The type of neonate feeding at discharge, 2, 4, 6, 9 and 12 months of life was reported by the mothers. Infectious diseases diagnosed in the first year of life, hospital admissions, primary care and emergency room consultations and drug treatments were obtained from neonate medical records. Health care costs were attributed using public prices and All Patients Refined–Diagnosis Related Groups (APR–DRG) classification. Results: Health care costs in the first year of life were higher in children artificially fed than in those breastfed (1339.5€, 95% confidence interval (CI): 903.0–1775.0 for artificially fed vs. 443.5€, 95% CI: 193.7–694.0 for breastfed). The breakdown of costs also shows differences in primary care consultations (295.7€ for formula fed children vs. 197.9€ for breastfed children), emergency room consultations (260.1€ for artificially fed children vs. 196.2€ for breastfed children) and hospital admissions (791.6€ for artificially fed children vs. 86.9€ for breastfed children). Conclusions: Children artificially fed brought about more health care costs related to infectious diseases than those exclusively breastfed or mixed breastfed. Excess costs were caused in hospital admissions, primary care consultations, emergency room consultations and drug consumption.

Download Full-text